Samsara BioCapital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $160K | Hold |
|
|||||
|
2024
Q2 | $375K | Hold |
|
|||||
|
2024
Q1 | $704K | Hold |
|
|||||
|
2023
Q4 | $393K | Hold |
|
|||||
|
2023
Q3 | $717K | Hold |
|
|||||
|
2023
Q2 | $972K | Hold |
|
|||||
|
2023
Q1 | $1.1M | Hold |
|
|||||
|
2022
Q4 | $1.01M | Hold |
|
|||||
|
2022
Q3 | $2.94M | Hold |
|
|||||
|
2022
Q2 | $2.68M | Sell |
|
|||||
|
2022
Q1 | $3.38M | Hold |
|
|||||
|
2021
Q4 | $2.6M | Hold |
|
|||||
|
2021
Q3 | $5.7M | Hold |
|
|||||
|
2021
Q2 | $8.06M | Sell |
|
|||||
|
2021
Q1 | $7.69M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.46M | Hold |
|
|||||
|
2019
Q4 | $2M | Buy |
|
|||||
|
2019
Q3 | $2.6M | Buy |
|
|||||
|
2019
Q2 | $1.53M | Sell |
|
|||||
|
2019
Q1 | $4.56M | Buy |
|